HARTFORD, Conn. - Former FDA Commissioner David Kessler stepped into the fray over how to regulate human cloning last week, saying that while the FDA has the authority, it lacks the regulatory framework and the resources to prevent the cloning of a human and other potentially unethical or unsafe biomedical experiments.

Kessler, now dean of the Yale University School of Medicine, also warned that the real issues arising from new biotechnology and drug products did not come from cloning or "Frankenstein" scenarios, but from the rising expense for new therapeutics, which he said threatened to bankrupt the health care system.